Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer - Chau,I.; Brown,G.; Cunningham,D. (J Clin Oncol, 2006)